Global X China Biotech Innovation ETF (CHB) Investment Research Dashboard
About Global X China Biotech Innovation ETF (CHB) stock analysis
Get live CHB stock price $6.64, comprehensive Global X China Biotech Innovation ETF stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time CHB stock data and investment insights.
Loading chart data...
Global X China Biotech Innovation ETF (CHB) Overview
Global X China Biotech Innovation ETF (CHB) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, CHB trades at $6.64 with a market capitalization of 1.39M . Over the past 52 weeks, CHB has traded between $6.63 and $9.76 , with the current price positioned at approximately 0% of this range . The stoc...
Key Takeaways
- Operates in the Financial Services sector (Asset Management)
- Market cap: 1.39M
- Current price: $6.64
- 52-week range: $6.63 - $9.76
- P/E ratio: 13.48
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
This fund commits at least 80% of its overall assets, alongside any borrowed capital used for investment, to the securities tracked by its benchmark index. This also includes American and Global Depositary Receipts that are derived from those same in...
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 13.5)
✓ Lower volatility stock (Beta: 0.66) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Global X China Biotech Innovation ETF shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Global X China Biotech Innovation ETF
- ⚠Investors should consider how Global X China Biotech Innovation ETF fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.39M
P/E Ratio (TTM)
13.48
Beta
0.66
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CHB with peer companies:
- Price
- $24.80+0.00% (1D)
- Market cap
- 1.24M
- Price
- $8.64+0.00% (1D)
- Market cap
- 1.28M
- Price
- $13.83+0.00% (1D)
- Market cap
- 1.36M
- Price
- $26.56+0.00% (1D)
- Market cap
- 1.34M
- Price
- $27.82+0.00% (1D)
- Market cap
- 1.47M
- Price
- $25.50+0.00% (1D)
- Market cap
- 1.24M
- Price
- $19.72+0.00% (1D)
- Market cap
- 1.48M
- Price
- $27.12+0.00% (1D)
- Market cap
- 1.36M
- Price
- $17.26+0.00% (1D)
- Market cap
- 1.32M
- Price
- $12.35+0.00% (1D)
- Market cap
- 1.65M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
83/100 ⭐⭐⭐⭐⭐
- Overall
- -0.4%
- NYSE
- -0.4%
- NASDAQ
- -0.3%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Communication Services | +0.4% | +3.4% | +2.7% | 22.3 | 90/100⭐⭐⭐⭐⭐ |
| Financial Services | -0.4% | +1.7% | +1.8% | 19.0 | 83/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +0.5% | +2.8% | +3.1% | 29.9 | 82/100⭐⭐⭐⭐⭐ |
| Healthcare | -0.8% | -0.9% | +1.6% | 23.9 | 66/100⭐⭐⭐⭐ |
| Energy | -0.4% | -3.5% | -3.1% | 19.4 | 59/100⭐⭐⭐⭐ |
| Basic Materials | -1.1% | -1.6% | -3.7% | 24.9 | 51/100⭐⭐⭐ |
| Real Estate | -1.6% | -3.3% | -3.9% | 28.7 | 39/100⭐⭐ |
| Consumer Cyclical | -0.3% | +0.0% | -7.4% | 41.9 | 38/100⭐⭐ |
| Utilities | -2.7% | -8.5% | -8.2% | 25.9 | 20/100⭐ |
| Industrials | -2.6% | -5.5% | -14.4% | 29.0 | 12/100⭐ |
| Technology | -2.5% | -7.7% | -12.7% | 39.8 | 11/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-30.